Sammamish, WA, United States of America

Stanley R Riddell

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 422(Granted Patents)


Location History:

  • Bothell, WA (US) (1998 - 2000)
  • Seattle, WA (US) (2023)
  • Sammamish, WA (US) (2015 - 2024)

Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: Innovations of Stanley R. Riddell in Cell Therapy and Immunotherapy

Introduction: Stanley R. Riddell is an eminent inventor based in Sammamish, WA, with an impressive portfolio of 25 patents. His contributions primarily focus on advancements in cell therapy and immunotherapy, areas that hold significant promise for treating various diseases, including cancer. His innovative approaches have not only enhanced treatment modalities but have also paved the way for groundbreaking methodologies in the medical field.

Latest Patents: Among his latest patents are the combination of a cell therapy and a gamma secretase inhibitor. This innovative therapy involves the use of immunotherapy combined with T cell therapy and a gamma secretase inhibitor, detailing methods for engineering, preparing, and producing the required cells and compositions. Additionally, he has developed tagged chimeric effector molecules and receptors that facilitate genetically engineering host cells for easier identification, isolation, and tracking. An example of this application is the recombinant modification of T cells for use in adoptive immunotherapy.

Career Highlights: Throughout his career, Stanley R. Riddell has made significant strides in the field of cancer research and therapy. He has been affiliated with renowned institutions such as Fred Hutchinson Cancer Center and Seattle Children's Hospital. His prolific work has influenced therapeutic strategies and offered novel solutions for complex health challenges.

Collaborations: Collaboration has been a crucial aspect of Riddell's work. He has had the opportunity to work alongside notable colleagues including Michael Hudecek and Michael C. Jensen. Together, they have contributed to significant advancements in research and the development of innovative therapies that have potential life-saving implications.

Conclusion: Stanley R. Riddell’s contributions to the fields of cell therapy and immunotherapy underscore the importance of innovation in medical research. His extensive patent portfolio reflects not only his dedication to advancing healthcare but also his commitment to developing effective treatment solutions. As researchers continue to build upon his groundbreaking work, the future of immunotherapy holds great promise for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…